Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
- 19 September 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (2), 632-642
- https://doi.org/10.1182/blood-2006-01-028423
Abstract
CD4+CD25+ regulatory T lymphocytes (Tregs) are specialized T cells playing a key role in the control of immune homeostasis. Here, we show that human Tregs constitutively express tyrosine hydroxylase (TH, EC 1.14.16.2), the rate-limiting enzyme in the synthesis of catecholamines, and contain substantial amounts of dopamine, norepinephrine, and epinephrine, which are released upon treatment with reserpine. Catecholamine release results in reduced production of interleukin-10 and transforming growth factor-β by Tregs, and in down-regulation of Treg-dependent inhibition of effector T-lymphocyte (Teff) proliferation, which occurs without affecting the production of tumor necrosis factor-α or interferon-γ. Tregs and Teffs express on the cell membrane both D1-like and D2-like dopaminergic receptors to a similar extent (12%-29% of the cells). Catecholamine-dependent down-regulation of Tregs is, however, selectively reversed by pharmacological blockade of dopaminergic D1-like receptors, which in Tregs only (and not in Teffs) are also expressed at the level of mRNA and are functionally coupled to intracellular production of cAMP. These findings indicate that in human Tregs endogenous catecholamines subserve an autocrine/paracrine loop involving dopaminergic pathways and resulting in down-regulation of Treg function.Keywords
This publication has 53 references indexed in Scilit:
- It takes nerve to tell T and B cells what to doJournal of Leukocyte Biology, 2006
- Dopamine Fails to Regulate Activation of Peripheral Blood Lymphocytes from Multiple Sclerosis Patients: Effects of IFN-βJournal of Interferon & Cytokine Research, 2005
- Dopaminergic regulation of immune cells via D 3 dopamine receptor: a pathway mediated by activated T cellsThe FASEB Journal, 2004
- Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applicationsImmunology Letters, 2004
- CD4+ CD25+ Treg: divide and rule?Immunology, 2004
- Cytokine Production by Naive and Primary Effector CD4+ T Cells Exposed to NorepinephrineBrain, Behavior, and Immunity, 2000
- α 1 -Adrenergic Receptor Subtypes in Human Peripheral Blood LymphocytesHypertension, 1999
- No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenicsNeuroscience Letters, 1996
- Dopamine receptor pharmacologyTrends in Pharmacological Sciences, 1994
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983